Women risk their lives by failing to take breast cancer drugs

Breast cancer patients are risking their lives by failing to take the tamoxifen they are prescribed, according to a new study published in the British Journal of Cancer.

Half of the women failed to finish a five year course of the drug and one in five regularly forget to take a tablet.

Experts already know that taking tamoxifen for five years increases survival chances and the new research reveals that women who miss at least one tablet every five days have a 10 per cent greater risk of dying.

The researchers - based at the University of Dundee and funded by the Medical Research Council and Breast Cancer Research (Scotland) - used the prescription records of more than 2000 women to see how many did not complete the standard treatment of a tamoxifen tablet every day and linked this to other health records to see if they were more likely to die.

The results show that 10 per cent of women followed for one year stopped taking tamoxifen, 19 per cent of the women followed for at least two years had stopped, 32 per cent of the women followed for three and a half years had stopped and a total of 51 per cent of women followed for five or more years had stopped taking the drug.

The study also showed that younger women were more likely to stop taking the medication early but there was no difference in the rich or poorer groups of women.

Professor Alastair Thompson, based at Ninewells Hospital Dundee and the senior breast specialist on the study, said: "This study paints a worrying picture. Tamoxifen is prescribed for five years to offer the best chance of surviving breast cancer, and not taking the tablets means that many women could be disadvantaged. Doctors and nurses should encourage patients to keep taking their prescribed medications, ensure side effects are managed as best as possible and thus get the maximum benefit from the medication."

Dr Lesley Walker, Cancer Research UK's director of information, said: "We know that tamoxifen saves lives, so these results are a real concern. It's not disastrous if women simply forget to take the occasional tablet but if they forget regularly and don't complete their treatment we need to know why. We need to make it clear that taking tamoxifen regularly for the full five years gives women the best chance of surviving breast cancer. If women are experiencing problems in taking any medication then we urge them to consult their doctor."

Advertisement

Comments

  1. Katrin R. Katrin R. United States says:

    I don't think women are taken seriously when they discuss the problems they are experiencing while taking this drug. In fact, the biggest problem with doctors is that they deny that 'the problems' are even related to Tamoxifen.

    And it's pretty serious when your femur begins to die, and you can no longer walk and have pain unlike you have ever experienced before? Or, you now need hand surgery?

  2. Karen Jones Squires Karen Jones Squires United States says:

    I was post-menopausal when I began taking Tamoxifen, and had stopped having PMS symptoms, but they came back with a vengeance on this drug. Leg cramps, numbness in my hands and feet and hot flashes started up. I really don't think those things would have happened had I not been on the drug. I switched to Aromasin, which hasn't caused hot flashes or PMS symptoms, but joint pain is worse, and it is very difficult to sleep at night.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post
You might also like... ×
QIAGEN receives first companion diagnostic approval in Japan